(via TheNewswire)

VANCOUVER, BC, Canada – TheNewswire - July 14, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) ("Noveris" or the "Company") is pleased to announce that, effective July 13, 2026, it has joined Life Sciences British Columbia ("Life Sciences BC" or "LSBC"), the not-for-profit industry association that supports and represents British Columbia’s life sciences community through leadership, investment, advocacy and promotion.

By joining LSBC, Noveris is strengthening its participation in British Columbia’s life sciences ecosystem and expanding opportunities to engage with innovators, strategic partners, investors, advisors and other sector stakeholders across the province. The Company believes that membership in LSBC will support greater visibility for Noveris within the local and national life sciences community while providing access to networking, industry programming and initiatives that help foster collaboration and commercialization.

“Joining Life Sciences BC reflects our commitment to being an active participant in British Columbia’s life sciences sector,” said Jason Birmingham, President & Chief Executive Officer of Noveris. “We see meaningful value in aligning with organizations that bring together scientific innovation, investment, advocacy and commercialization support, and we look forward to contributing to and benefiting from the LSBC community as we continue to advance Noveris’ strategic priorities.”

Life Sciences BC serves as a key industry platform for connecting companies, researchers, institutions and capital providers, and Noveris expects its membership to enhance the Company’s profile within the broader healthcare and biotechnology landscape. The Company also anticipates participation in LSBC events, member programming and sector initiatives that can help support relationship-building, knowledge-sharing and long-term strategic development.

About Noveris Health Sciences Inc.

Noveris Health Sciences Inc. is a biotechnology company focused on the development, advancement and commercialization of healthcare technologies and opportunities addressing unmet needs in the market. The Company’s common shares trade on the Canadian Securities Exchange under the symbol NVRS, on the Frankfurt Stock Exchange under the symbol 0NF0, and on the OTC market under the symbol MYCOF.

For more information, visit www.noveris.health .

About Life Sciences British Columbia

Life Sciences British Columbia is a not-for-profit, non-government industry association that supports and represents the life sciences community of British Columbia through leadership, investment, advocacy and promotion. LSBC offers member services, sector programming, networking opportunities and initiatives designed to strengthen British Columbia’s life sciences ecosystem.

For further information:

Noveris Health Sciences Inc.
Jason Birmingham
President & Chief Executive Officer
Telephone: +1 (778) 900-6877
Email: fair@noveris.health
Website: www.noveris.health

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release. .

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Forward-looking statements in this news release include, but are not limited to, statements regarding the anticipated benefits of the Company’s membership in Life Sciences BC, including increased visibility, collaboration opportunities, stakeholder engagement, participation in events and programming, and support for the Company’s strategic development and commercialization objectives. Forward-looking statements are often identified by words such as “expects,” “believes,” “will,” “anticipates,” “plans,” and similar expressions, or statements that certain actions, events or results “may,” “could,” or “should” occur.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs as of the date of this news release and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties may include, without limitation, changes in business, market, economic or regulatory conditions, the Company’s ability to realize the expected benefits of its LSBC membership, and other risks associated with the Company’s business and operations.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

Copyright (c) 2026 TheNewswire - All rights reserved.